ReviewArchives of microbiology2021
Mimosa tenuiflora's antimicrobial activity on bacteria and fungi from medical importance: an integrative review.
Review in Archives of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Unraveling the organellar genomic landscape of the therapeutic and entheogenic plant Mimosa tenuiflora: insights into genetic, structural, and evolutionary dynamics.Functional & integrative genomics · 2024Article
- Evidence for Natural Products as Alternative Wound-Healing Therapies.Biomolecules · 2023Review
- In Vitro Cytotoxic Activity of Methanol Extracts of Selected Medicinal Plants Traditionally Used in Mexico against Human Hepatocellular Carcinoma.Plants (Basel, Switzerland) · 2022Article
- Preliminary Study of the Antimicrobial, Anticoagulant, Antioxidant, Cytotoxic, and Anti-Inflammatory Activity of Five Selected Plants with Therapeutic Application in Dentistry.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The misuse of antimicrobials has led to the appearance of several multi-resistant pathogens and, as a result, it has been necessary to search for new compounds that are effective against these microorganisms. Faced with this scenario, one of the forms that has been arousing the interest of scholars is the obtaining of antimicrobial compounds from medicinal plants, since, through them, effective compounds are usually obtained against pathogens and with low toxicity to humans and animals. In Brazilian Caatinga, there are several medicinal plants with antimicrobial properties, and one of them is Mimosa tenuiflora (Willd.) Poir., also known as Jurema Preta, popularly used to treat comorbidities that affect mainly the skin. In view of this, to investigate its antimicrobial potential, a bibliographical survey of experimental articles, published in the last 10 years, which analyzed the antimicrobial activity of M. tenuiflora in bacteria and fungi of importance, was made. Thus, it was possible to observe that the extracts obtained from M. tenuiflora showed in vitro antimicrobial activity. In addition, the compounds flavonoids and tannins are likely to be the main responsible for Mimosa tenuiflora's antimicrobial activity. Thus, M. tenuiflora presents a high study potential in microbial growth control.
Indexed as
Identifiers
33885936What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.